Page last updated: 2024-08-24

toxoflavin and Sarcoma

toxoflavin has been researched along with Sarcoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alemany, R; Calabuig-Fariñas, S; Felipe-Abrio, I; Martín-Broto, J; Martinez-Font, E; Obrador-Hevia, A; Ramos, R; Terrasa, J; Vögler, O	1

Other Studies

1 other study(ies) available for toxoflavin and Sarcoma

Article	Year
Disruption of TCF/β-Catenin Binding Impairs Wnt Signaling and Induces Apoptosis in Soft Tissue Sarcoma Cells. Molecular cancer therapeutics, 2017, Volume: 16, Issue:6 Topics: Antineoplastic Agents; Apoptosis; beta Catenin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Doxorubicin; Drug Synergism; Humans; Protein Binding; Pyrimidinones; Sarcoma; TCF Transcription Factors; Triazines; Wnt Signaling Pathway	2017

Article

Year

Disruption of TCF/β-Catenin Binding Impairs Wnt Signaling and Induces Apoptosis in Soft Tissue Sarcoma Cells.

Molecular cancer therapeutics, 2017, Volume: 16, Issue:6

Topics: Antineoplastic Agents; Apoptosis; beta Catenin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Doxorubicin; Drug Synergism; Humans; Protein Binding; Pyrimidinones; Sarcoma; TCF Transcription Factors; Triazines; Wnt Signaling Pathway

2017